Nutcracker Therapeutics is a biotechnology company that develops gene therapies for the treatment of genetic diseases. The company's platform uses CRISPR technology to edit genes and correct genetic mutations that cause diseases. Nutcracker Therapeutics' mission is to provide effective and affordable gene therapies to patients in need. The company was founded in 2019 and is based in San Francisco, California.